Aquatic Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$816K Buy
+89,677
New +$1.13M 0.02% 612
2025
Q3
Sell
-3,618
Closed -$43.2K 1425
2025
Q2
$43.2K Sell
3,618
-1,774
-33% -$22.3K ﹤0.01% 1152
2025
Q1
$64.1K Buy
+5,392
New +$83.8K ﹤0.01% 1120
2023
Q1
Sell
-3,200
Closed -$27K 1326
2022
Q4
$27K Buy
3,200
+1,200
+60% +$11.4K ﹤0.01% 1121
2022
Q3
$21K Buy
+2,000
New +$26.4K ﹤0.01% 991

Other funds holding CLPT

Aquatic Capital Management's CLPT Position: Q1 2026 in Review

Aquatic Capital Management opened a new position in ClearPoint Neuro (CLPT) in Q1 2026: 89,677 shares worth $816K. The stake represents 0.02% of the portfolio and ranks #612 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in CLPT as recently as Q2 2025.

Aquatic Capital Management first reported a position in CLPT in Q3 2022 and has held it in 5 quarters since. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Aquatic Capital Management held 89,677 shares of ClearPoint Neuro worth $816K as of Q1 2026.
  • ClearPoint Neuro was a new Aquatic Capital Management position in Q1 2026.
  • ClearPoint Neuro made up 0.02% of Aquatic Capital Management's portfolio in Q1 2026, its #612 holding.
  • Aquatic Capital Management first reported a position in ClearPoint Neuro in Q3 2022 and has held it in 5 quarters since.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.